hydroxyproline has been researched along with goserelin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Silfvast, A; Simberg, N; Tiitinen, A; Viinikka, L; Ylikorkala, O | 1 |
| Amama, EA; Minaguchi, H; Taga, M | 1 |
1 trial(s) available for hydroxyproline and goserelin
| Article | Year |
|---|---|
High bone density in hyperandrogenic women: effect of gonadotropin-releasing hormone agonist alone or in conjunction with estrogen-progestin replacement.
Topics: Adult; Alkaline Phosphatase; Bone and Bones; Bone Density; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Gonadotropin-Releasing Hormone; Goserelin; Hirsutism; Humans; Hydroxyproline; Hyperandrogenism; Medroxyprogesterone Acetate; Testosterone | 1996 |
1 other study(ies) available for hydroxyproline and goserelin
| Article | Year |
|---|---|
The effect of gonadotropin-releasing hormone agonist on type I collagen C-telopeptide and N-telopeptide: the predictive value of biochemical markers of bone turnover.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Antineoplastic Agents, Hormonal; Biomarkers; Bone Remodeling; Buserelin; Collagen; Collagen Type I; Endometriosis; Estradiol; Female; Goserelin; Humans; Hydroxyproline; Leiomyoma; Osteocalcin; Peptides; Retrospective Studies | 1998 |